Skip to content

The COPE LBP trial: Cognitive Patient Education for Low Back Pain

The COPE LBP trial: Cognitive Patient Education for Low Back Pain - a cluster randomised controlled trial in primary care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN04323845
Enrollment
300
Registered
2009-05-11
Start date
2009-01-14
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-specific low back pain Musculoskeletal Diseases Dorsalgia

Interventions

Stratified cluster randomised controlled trial with family doctors (GP) and physiotherapists (PT) as unit for randomisation. Follow-up after intervention at 4 - 5 weeks, and at 3, 6, and 12 months. T

Sponsors

Oslo University Hospital (Norway)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Each practitioner will recruit up to 10 patients, aged 20 to 55 years (either sex), with non-specific subacute/chronic low back pain (LBP) of less than 1 year duration.

Exclusion criteria

Exclusion criteria: 1. Provider's uncertainty of diagnosis 2. Possible nerve root pain or severe pathology 3. Signs of any 'red flags' 4. Particular interest or demand for a specific treatment

Design outcomes

Primary

MeasureTime frame
Function (disability) assessed by the Roland Morris Disability Questionnaire (RMQ), a self-administered questionnaire with score 0 - 24, with 0 corresponding to no disability.

Secondary

MeasureTime frame
1. Pain; measured on a numerical rating scale from 0 to 10 2. Return to work; reported as number of days from first visit to the health care provider until completely or partially return to work - and as a total number of days absent from work the following year 3. Overall satisfaction; measured on a numerical rating scale from 0 to 10 4. Health related quality of life; assessed by the EuroQoL-5D and Patient-Generated Index (PGI) 5. A cost-effectiveness analysis will be carried out by using both the return-to work outcome and the EuroQoL 5D, and by estimating the total cost of all the four groups of doctors and physiotherapists in this trial

Countries

Norway

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 1, 2026